Subscribe to Surgical Products Magazine News
View Sample

FREE Email Newsletter

Surgical Products Daily

Growth And Expansion Accelerate Orthopedic Industry Innovation

February 14, 2012 8:38 am | Comments

(BUSINESS WIRE)-- KFx Medical Corporation, an emerging leader in soft tissue disease repair and bone implant products, today announced a third new patent grant. The new patent (U.S. Patent No. 8,109,969 designated for knotless double row soft tissue to bone repair method) was secured in only 4 months via participation in the USPTO Patent Accelerated Examination Program.

Doctors Urge More Production Of Scarce Cancer Drug

February 14, 2012 8:33 am | Comments

TRENTON, N.J. (AP) — Four pharmaceutical companies that make a crucial cancer drug for children that's suddenly in short supply are being urged to try to quickly step up production to prevent unnecessary deaths. A senator and three doctor groups late Monday sent the pleas to the companies, saying that hospitals will run out of the drug in days to weeks, increasing chances that young patients who might otherwise survive will die.

Truly Informed

February 14, 2012 8:17 am | by Jon Minnick | Comments

The majority of my family members are part of the aging population, and as such, see doctors frequently to improve their quality of life or discuss their latest ailment. Any time they learn of a procedure they’d be required to go through to extend their life, they intently listen to what the process entails and religiously read the take-home literature.


Nerve Sparing Allows For Reaching Same Orgasms As Before Surgery

February 13, 2012 6:56 am | Comments

The vast majority of men who have a prostate cancer operation can retain their ability to orgasm if the surgery is carried out without removing the nerves that surround the prostate gland like a hammock, according to a study in the February issue of the urology journal BJUI . American researchers from Cornell University studied 408 patients who received robot-assisted laparoscopic radical prostatectomy (RALP) from a single surgeon between January 2005 and June 2007.

Delaying ACL Reconstruction In Kids May Lead To More Injuries

February 13, 2012 6:46 am | Comments

(PRNewswire-USNewswire) Kids treated more than 150 days after an Anterior Cruciate Ligament (ACL) injury have higher rates of other knee injuries, including medial meniscal tears, say researchers presenting at the American Orthopaedic Society for Sports Medicine. "In our research, children who had delayed treatment of an ACL injury more than 150 days, tended to have an increased chance of also having a medial meniscus or chondral injury in their knee.

Induced Labor Lets Dying Man See His Daughter

February 13, 2012 6:39 am | Comments

Jamie Stengle, AP Diane Aulger was about two weeks from her delivery date when she and her husband decided there was no time to wait. Mark Aulger had only days to live and he wanted to see his child. Diane Aulger had her labor induced and gave birth to their daughter. When tiny Savannah was placed in his arms, Mark Aulger "cried, and he just looked very sad," his wife said.

Nearly One In Twenty Over Age 50 Have Fake Knees

February 13, 2012 6:32 am | Comments

Lindsey Tanner, AP Nearly one in 20 Americans older than 50 have artificial knees, or more than four million people, according to the first national estimate showing how common these replacement joints have become in an aging population. Doctors know the number of knee replacement operations has surged in the past decade, especially in baby boomers.

Annual Cost Of Defensive Orthopaedic Medicine Estimated At $2 Billion

February 10, 2012 8:42 am | Comments

/PRNewswire-USNewswire/ -- In a first-ever national survey of orthopaedic surgeons, 96 percent said they have practiced defensive medicine - the ordering of tests, referrals to specialists and hospital admissions primarily to avoid liability and without significant benefit to patients - according to a new study presented today at the 2012 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS).


Clinical Results Distance Resurfacing System From Failed Hip Implants

February 10, 2012 8:36 am | Comments

/PRNewswire/ -- Smith & Nephew (NYSE:SNN; LSE:SN), the global medical technology business, today announced the results of a new study for its BIRMINGHAM HIPT Resurfacing (BHR) System. The study, carried out at the request of the FDA, followed the progress of the first 400 BHR patients in the United Kingdom and found that after 10 years, 99% were either satisfied or extremely satisfied with their BHR procedure.

Results From Clinical Trial To Prevent Acute Radiation Enteritis

February 10, 2012 8:30 am | Comments

/PRNewswire/ -- Soligenix, Inc. (OTCBB: SNGXD) (Soligenix or the Company), a development stage biopharmaceutical company, announced preliminary results today from a Phase 1/2 clinical trial evaluating SGX201, a time-release formulation of oral beclomethasone 17,21-dipropionate (oral BDP), for the prevention of acute radiation enteritis.

TKR Surgeries More Than Doubled Over Past Decade

February 10, 2012 8:24 am | Comments

/PRNewswire-USNewswire/ -- New research presented at the 2012 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) found that more than 4.5 million Americans are living with a total knee replacement (TKR), as the number of TKR surgeries has more than doubled over the past decade, with the sharpest rise among younger patients.

Clinical Study To Evaluate Effectiveness Of Engineered Juvenile Cartilage

February 8, 2012 8:32 am | Comments

Zimmer Holdings, Inc. (NYSE and SIX: ZMH), a global leader in musculoskeletal health, and ISTO Technologies, Inc., an orthobiologics company focused on developing breakthrough products to regenerate and restore function to damaged cartilage and bone, today announced a Phase III clinical study to evaluate DeNovo ® ET Engineered Tissue Graft, an engineered cartilage implant intended to repair cartilage defects in the knee.

Lap-Band Surgeries Halted At Two LA Clinics

February 8, 2012 8:14 am | Comments

Two Los Angeles-area outpatient clinics affiliated with the 1-800 GET-THIN marketing company have temporarily stopped Lap-Band weight-loss surgeries while they conduct a review of the procedure. The move follows Irvine-based Allergan's announcement last week that it would stop selling the device to companies affiliated with the ad campaign.

Innovative Device Treats Complete Blockages In Peripheral Arteries

February 8, 2012 8:10 am | Comments

/PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announces the U.S. launch of the TruePathT CTO Device, designed to facilitate the crossing of chronic total occlusions (CTOs, or complete blockages) within the peripheral vasculature. The Company will begin marketing the product immediately in the U.

Woman Gets Probation For Fake Cancer Claims

February 8, 2012 8:03 am | Comments

WASHINGTON, Pa. (AP) — A Pennsylvania woman who submitted nearly $100,000 worth of fake cancer treatment insurance claims for herself and her husband must repay the money while she serves nearly nine years on probation. Brown pleaded guilty in August to submitting the phony claims from August 2006 through May 2008.


You may login with either your assigned username or your e-mail address.
The password field is case sensitive.